• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND ARCHITECT ANTI-HBS REAGENT KIT; TEST, HEPATITIS B (B CORE, BE ANTIGEN, BE ANTIBODY, B CORE IGM)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND ARCHITECT ANTI-HBS REAGENT KIT; TEST, HEPATITIS B (B CORE, BE ANTIGEN, BE ANTIBODY, B CORE IGM) Back to Search Results
Catalog Number 07C18-78
Device Problem High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 06/26/2021
Event Type  malfunction  
Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.This report is being filed on an international product, list number 07c18 that has a similar product distributed in the us, list number 01l82.
 
Event Description
The customer observed a (b)(6) architect (b)(6) result for one patient diagnosed with chronic granulocytic leukemia.Per the record, the patient had received a blood transfusion on (b)(6) 2021.The architect (b)(6) result on (b)(6) 2021 was (b)(6); the previous result was (b)(6).No adverse impact to patient management was reported.
 
Event Description
The customer observed a false reactive architect anti-hbs result for one patient diagnosed with chronic granulocytic leukemia.Per the record, the patient had received a blood transfusion on (b)(6) 2021.The architect anti-hbs result on (b)(6) 2021 was 17 miu/ml (reference range =10 miu/ml); the previous result was negative.No adverse impact to patient management was reported.Update: the patient is male.The sample was retested on another i2000sr instrument at the customer¿s site, and the result was 15 miu/ml.
 
Manufacturer Narrative
Additional information found in the following fields: a3.Gender.B5.Describe event.D4.Lot no.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Manufacturer Narrative
The complaint investigation included a search for similar complaints, and the review of the complaint text, trending data, labelling, and device history records.Return testing was not completed as returns were not available.A review of tracking and trending did not identify any trends for the complaint issue.Device history record review did not identify any issues associated with lot 24116fn01 and the complaint issue.Historical performance was evaluated using worldwide field data and indicated that the patient median result for the lot is comparable with all other lots in the field and within established baselines, confirming no systemic issue for the product lot.Labelling was reviewed which adequately addresses the issue under review.If the anti-hbs results are inconsistent with clinical evidence, additional testing is suggested to confirm the result.For diagnostic purposes, results should be used in conjunction with patient history and other hepatitis markers for diagnosis of acute, chronic, or recovered infection.Based on the investigation, no systemic issue or deficiency of the architect anti-hbs assay, lot number 24116fn01 was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT ANTI-HBS REAGENT KIT
Type of Device
TEST, HEPATITIS B (B CORE, BE ANTIGEN, BE ANTIBODY, B CORE IGM)
Manufacturer (Section D)
ABBOTT IRELAND
finisklin business park
sligo F91VY 44
EI  F91VY44
MDR Report Key12122359
MDR Text Key260079469
Report Number3008344661-2021-00136
Device Sequence Number1
Product Code LOM
Combination Product (y/n)N
PMA/PMN Number
P050051
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup,Followup
Report Date 08/31/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/06/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/21/2022
Device Catalogue Number07C18-78
Device Lot Number24116FN01
Was Device Available for Evaluation? No
Date Manufacturer Received08/30/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARC I2000SR INST, 03M74-02, (B)(6).; ARC I2000SR INST, 03M74-02, (B)(6).; ARC I2000SR INST, 03M74-02, (B)(6).; ARC I2000SR INST, 03M74-02, ISR61756
-
-